These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 9398398

  • 1. Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells.
    Grohmann U, Silla S, Belladonna ML, Bianchi R, Orabona C, Puccetti P, Fioretti MC.
    Cell Immunol; 1997 Nov 01; 181(2):109-19. PubMed ID: 9398398
    [Abstract] [Full Text] [Related]

  • 2. Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo.
    Fallarino F, Uyttenhove C, Boon T, Gajewski TF.
    J Immunol; 1996 Feb 01; 156(3):1095-100. PubMed ID: 8557984
    [Abstract] [Full Text] [Related]

  • 3. CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide.
    Grohmann U, Bianchi R, Fioretti MC, Fallarino F, Binaglia L, Uyttenhove C, Van Pel A, Boon T, Puccetti P.
    Eur J Immunol; 1995 Oct 01; 25(10):2797-802. PubMed ID: 7589074
    [Abstract] [Full Text] [Related]

  • 4. IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells.
    Bianchi R, Grohmann U, Belladonna ML, Silla S, Fallarino F, Ayroldi E, Fioretti MC, Puccetti P.
    J Immunol; 1996 Aug 15; 157(4):1589-97. PubMed ID: 8759743
    [Abstract] [Full Text] [Related]

  • 5. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity.
    Piccotti JR, Chan SY, Goodman RE, Magram J, Eichwald EJ, Bishop DK.
    J Immunol; 1996 Sep 01; 157(5):1951-7. PubMed ID: 8757314
    [Abstract] [Full Text] [Related]

  • 6. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer.
    Song K, Chang Y, Prud'homme GJ.
    Gene Ther; 2000 Mar 01; 7(6):481-92. PubMed ID: 10757021
    [Abstract] [Full Text] [Related]

  • 7. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D, Valujskikh A, Pearlman E, Higgins AW, Gilliam AC, Heeger PS.
    J Immunol; 1998 Nov 15; 161(10):5236-44. PubMed ID: 9820495
    [Abstract] [Full Text] [Related]

  • 8. Importance of B7-1-expressing host antigen-presenting cells for the eradication of B7-2 transfected P815 tumor cells.
    La Motte RN, Sharpe AH, Bluestone JA, Mokyr MB.
    J Immunol; 1998 Dec 15; 161(12):6552-8. PubMed ID: 9862681
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer.
    Rodolfo M, Zilocchi C, Accornero P, Cappetti B, Arioli I, Colombo MP.
    J Immunol; 1999 Aug 15; 163(4):1923-8. PubMed ID: 10438927
    [Abstract] [Full Text] [Related]

  • 11. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis.
    Romani L, Mencacci A, Tonnetti L, Spaccapelo R, Cenci E, Puccetti P, Wolf SF, Bistoni F.
    J Immunol; 1994 Dec 01; 153(11):5167-75. PubMed ID: 7963574
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Graft survival and cytokine production profile after limbal transplantation in the experimental mouse model.
    Lenčová A, Pokorná K, Zajícová A, Krulová M, Filipec M, Holáň V.
    Transpl Immunol; 2011 Apr 15; 24(3):189-94. PubMed ID: 21118723
    [Abstract] [Full Text] [Related]

  • 14. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
    Amel-Kashipaz MR, Huggins ML, Lanyon P, Robins A, Todd I, Powell RJ.
    J Autoimmun; 2001 Sep 15; 17(2):155-63. PubMed ID: 11591124
    [Abstract] [Full Text] [Related]

  • 15. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity.
    Tatsumi T, Huang J, Gooding WE, Gambotto A, Robbins PD, Vujanovic NL, Alber SM, Watkins SC, Okada H, Storkus WJ.
    Cancer Res; 2003 Oct 01; 63(19):6378-86. PubMed ID: 14559827
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response.
    Adris S, Klein S, Jasnis M, Chuluyan E, Ledda M, Bravo A, Carbone C, Chernajovsky Y, Podhajcer O.
    Gene Ther; 1999 Oct 01; 6(10):1705-12. PubMed ID: 10516719
    [Abstract] [Full Text] [Related]

  • 18. Co-stimulated/Tc2 cells abrogate murine marrow graft rejection.
    Erdmann AA, Jung U, Foley JE, Toda Y, Fowler DH.
    Biol Blood Marrow Transplant; 2004 Sep 01; 10(9):604-13. PubMed ID: 15319772
    [Abstract] [Full Text] [Related]

  • 19. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
    Chow YH, Chiang BL, Lee YL, Chi WK, Lin WC, Chen YT, Tao MH.
    J Immunol; 1998 Feb 01; 160(3):1320-9. PubMed ID: 9570550
    [Abstract] [Full Text] [Related]

  • 20. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M, Falkner DH, Morel PA.
    J Leukoc Biol; 2005 Sep 01; 78(3):656-64. PubMed ID: 15961574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.